<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PRTK
Paratek Pharmaceuticals
$
()


  • Four new option listings and nineteen option delistings on October 24th

    10/24/2023 - 08:30am
  • Gurnet Point, Novo complete acquisition of Paratek Pharmaceuticals

    9/21/2023 - 09:04am
  • Paratek announces stockholder approval of acquisition by Gurnet, Novo

    9/18/2023 - 09:40am
  • Paratek Pharmaceuticals reports Q2 EPS (25c), consensus (31c)

    8/3/2023 - 08:09am
  • NexPoint issues demand letter to Paratek Pharmaceuticals

    7/11/2023 - 16:19pm
  • Paratek Pharmaceuticals announces modification of BARDA contract

    7/10/2023 - 08:04am
  • Paratek Pharmaceuticals acknowledges receipt of NexPoint letter

    6/27/2023 - 12:03pm
  • NexPoint to withhold its votes against all three Paratek Board members

    6/27/2023 - 08:05am
  • Paratek announces COMP recommends orphan drug designation for NUZYRA

    6/27/2023 - 08:03am
  • Biotech Alert: Searches spiking for these stocks today

    6/8/2023 - 11:05am
  • Paratek Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

    6/7/2023 - 06:12am
  • Paratek Pharmaceuticals downgraded to Hold from Buy at Jefferies

    6/7/2023 - 05:04am
  • Paratek Pharmaceuticals trading resumes

    6/6/2023 - 09:50am
  • Paratek to be acquired by Gurnet, Novo for $2.15 per share plus 85c CVR

    6/6/2023 - 09:08am
  • Paratek Pharmaceuticals trading halted, news pending

    6/6/2023 - 08:40am
dynamic_feed Breaking News